Enveric Biosciences, Inc. Deferred Foreign Income Tax Expense (Benefit)
Discontinued › Expense Statement › Income Tax
us-gaap:DeferredForeignIncomeTaxExpenseBenefit · last filed 2024-03-26
- Enveric Biosciences, Inc. deferred foreign income tax expense (benefit) for fiscal 2022 was -$1.49M, a 119.93% decline from fiscal 2021.
- Enveric Biosciences, Inc. deferred foreign income tax expense (benefit) for fiscal 2021 was $7.45M.
- Enveric Biosciences, Inc. deferred foreign income tax expense (benefit) for fiscal 2019 was $13.19K, a 46.12% decline from fiscal 2018.
- Enveric Biosciences, Inc. deferred foreign income tax expense (benefit) for fiscal 2018 was $24.48K.
| Period end | Deferred Foreign Income Tax Expense (Benefit) 12 month | Deferred Foreign Income Tax Expense (Benefit) 12 month as first filed |
|---|---|---|
| 2022-12-31 | -$1.49M 10-K · filed 2024-03-26 | $1.49M 10-K · filed 2023-03-31 |
| 2021-12-31 | $7.45M 10-K/A · filed 2023-06-09 | |
| 2019-12-31 | $13.19K 10-K/A · filed 2020-08-12 | |
| 2018-12-31 | $24.48K 10-K/A · filed 2020-08-12 | |
| 2017-12-31 | $0.00 10-K · filed 2019-03-26 | |
| 2016-12-31 | $0.00 10-K · filed 2018-04-02 |